查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1489302

全球類器官市場：2033 年的機會與策略

Organoids Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 309 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2018年全球類器官市場價值為13.0605億美元，到2023年複合年成長率將超過20.00%。

對個人化醫療的需求不斷增加

對個人化醫療的需求不斷成長推動了類器官市場的成長。個人化醫療，也稱為精準醫療或個人化醫療，是一種醫療方法，旨在提供適合每個患者特徵的治療和介入措施。類器官複製個別患者特徵的能力已成為根據特定遺傳特徵和疾病特徵量身定做治療的重要工具。需求的激增提高了類器官在藥物測試、疾病建模和精準醫學應用中的重要性和採用率。例如，2022 年 10 月，代表科學家、患者和醫療保健提供者的美國組織個人化醫療聯盟宣布，多種類型的癌症、遺傳性罕見疾病以及我們估計有超過 75,000 種基因檢測產品和市場上有300多種針對慢性病和感染疾病患者的個人化藥物。此外，根據倡導個人化醫療的美國個人化醫療聯盟（PMC）預計，預計2022年美國食品藥物管理局新藥認證中個人化藥品將佔到34%，其中個人化藥品佔比更高；超過25%的核准。因此，個人化醫療需求的不斷成長支撐了歷史時期類器官市場的成長。

目錄

第1章執行摘要

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章市場特點

  • 一般市場定義
  • 概述
  • 類器官市場定義與細分
  • 市場區隔：按產品
    • 肝臟類器官
    • 結腸類器官
    • 腸類器官
    • 其他
  • 市場區隔：按應用
    • 發育生物學
    • 感染疾病病理學
    • 再生醫學
    • 測試藥物毒性和功效
    • 藥物發現與個人化醫療
    • 其他
  • 市場區隔：依最終用途產業
    • 醫院和診斷中心
    • 生物製藥公司
    • 學術機構/研究機構
    • 受託研究機構
  • 市場區隔：依原產地
    • 多功能能幹細胞
    • 器官特異性成體幹細胞

第7章 主要市場趨勢

  • 擴展解決方案，重點關注生物製藥研究的類器官解決方案
  • 創建專門的 3D 細胞模型的生命科學研究進展
  • 開發基於心臟類器官的套件以改善心臟安全測試
  • 策略夥伴關係與協作，推動下一代類器官技術
  • 專注於高通量應用的客自訂類器官生產線服務
  • 更多採用 3D 細胞培養技術來加速類器官和細胞收穫

第 8 章類器官市場：宏觀經濟情景

  • COVID-19 的影響：類器官市場
  • 烏克蘭戰爭的影響：類器官市場
  • 高通膨的影響：類器官市場

第9章世界市場規模與成長

  • 市場規模
  • 2018-2023 年市場成長表現
    • 2018-2023年市場促進因素
    • 2018-2023年市場限制因素
  • 市場成長預測，2023-2028，2033F
    • 2023-2028年市場促進因素
    • 2023-2028年市場限制因素

第10章全球類器官市場：細分

  • 全球類器官市場：按產品、性能和預測，2018-2023、2028F、2033F
  • 全球類器官市場：按應用、性能和預測，2018-2023、2028F、2033F
  • 全球類器官市場：最終用途產業的實際狀況與預測，2018-2023、2028F、2033F
  • 全球類器官市場：按來源、性能和預測，2018-2023、2028F、2033F

第11章類器官市場：區域/國家分析

  • 全球類器官市場：按地區、績效及預測，2018-2023、2028F、2033F
  • 全球類器官市場：依國家、績效及預測，2018-2023、2028F、2033F

第12章亞太市場

第13章西歐市場

第14章 東歐市場

第15章 北美市場

第16章 南美洲市場

第17章 中東市場

第18章 非洲市場

第19章 競爭格局及公司概況

  • 公司簡介
  • Thermo Fisher Scientific Inc
  • Carl Zeiss AG
  • Corning Incorporated
  • Lonza Group Ltd
  • STEMCELL Technologies Inc

第20章 競爭基準化分析

第 21 章競爭對手儀表板

第22章 重大併購

  • Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
  • Bruker Corporation Acquired Acquifer Imaging
  • Molecular Devices Acquired Cellesce
  • Crown Bioscience International Acquired OcellO

第23章機遇與策略

  • 全球類器官市場：提供新機會的國家
  • 全球類器官市場：提供新機會的細分市場
  • 全球類器官市場：成長策略

第24章類器官市場：結論與建議

  • 結論
  • 推薦

第25章附錄

簡介目錄
Product Code: o&s1233

Organoids are three-dimensional cell cultures that mimic the structural and functional characteristics of real organs. These miniature, simplified versions of organs are grown from stem cells in a laboratory environment to replicate some of the complex biological structures and processes of their full-sized counterparts.

The organoids market consists of sales, by entities (organizations, sole traders and partnerships), of organoids products that are a revolutionary tool in modern biomedical research and medicine, enabling scientists and doctors to study human development, disease progression and drug responses in a controlled and replicable way.

The global organoids market was valued at $1,306.05 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 20.00%.

Increase In Demand For Personalized Medicine

An increase in demand for personalized medicine propelled the growth of the organoids market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Organoids, with their ability to replicate individual patient characteristics, have become indispensable tools in tailoring medical treatments to specific genetic profiles and disease characteristics. This demand surge has elevated the significance and adoption of organoids in drug testing, disease modeling and precision medicine applications. For instance, in October 2022, the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system), estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, according to the Personalized Medicine Coalition (PMC), a US-based company that advocates for personalized medicine, personalized medicines were estimated to account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the increase in demand for personalized medicine supported the growth of the organoids market during the historic period.

Advancements In Life Science Research For The Production Of Specialized 3D Cell Models

Companies are focusing on advancements in life science research for the production of specialized 3D organoids, representing a substantial stride in biomedical advancement. These pioneering advancements entail crafting organoids that closely emulate the structural and functional intricacies of human organs, granting researchers an unparalleled understanding of disease mechanisms and drug reactions. For example, in February 2024, Cell Microsystems, a US-based biotechnology company that provides advanced tools for cell biology, announced a strategic partnership with OMNI Life Science (OLS), a Germany-based cell biology company. This collaboration endeavors to launch three groundbreaking products-CERO, CASY and TIGR-into the US and Canadian markets, advancing life science research in North America. The CERO 3D, a pioneering instrument, fosters an ideal cell culture environment for producing specialized 3D cell models, such as stem cells, spheroids, organoids and tissues.

The global organoids market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.50% of the total market in 2022.

Organoids Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organoids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application, by end-use industries and by source.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the organoids market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application, by end-use industries and by source in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Competitive Benchmarking -Briefs on the financials comparison between major players in the market.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for organoids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Hepatic Organoids; Colorectal Organoids; Intestinal Organoids; Other Organoids
  • 2) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
  • 3) By End-Use Industries: Hospitals And Diagnostic Centers; Biopharmaceutical Companies; Academics And Research Institutes; Contract Research Organizations
  • 4) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Carl Zeiss AG; Corning Incorporated; Lonza Group Ltd.; STEMCELL Technologies Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Organoids - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Organoids Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Hepatic Organoids
    • 6.4.2 Colorectal Organoids
    • 6.4.3 Intestinal Organoids
    • 6.4.4 Other Organoids
  • 6.5 Market Segmentation By Application
    • 6.5.1 Developmental Biology
    • 6.5.2 Disease Pathology Of Infectious Disease
    • 6.5.3 Regenerative Medicine
    • 6.5.4 Drug Toxicity And Efficacy Testing
    • 6.5.5 Drug Discovery And Personalized Medicine
    • 6.5.6 Other Applications
  • 6.6 Market Segmentation by End-Use Industries
    • 6.6.1 Hospitals And Diagnostic Centers
    • 6.6.2 Biopharmaceutical Companies
    • 6.6.3 Academics and Research Institutes
    • 6.6.4 Contract Research Organizations
  • 6.7 Market Segmentation By Source
    • 6.7.1 Pluripotent Stem Cells
    • 6.7.2 Organ-Specific Adult Stem Cells

7 Major Market Trends

  • 7.1 Focus On Organoid Solutions For Biotherapeutic Research And To Expand Solutions
  • 7.2 Advancements In Life Science Research For The Production Of Specialized 3D Cell Models
  • 7.3 Development Of Cardiac Organoids-Based Kits For Improved Cardiac Safety Testing
  • 7.4 Strategic Partnerships And Collaborations To Advance Next-Generation Organoids Technology
  • 7.5 Focus On Custom Organoid Line Services For High-Throughput Applications
  • 7.6 Rising Adoption Of 3D Cell Culture Techniques To Expedite Organoid And Cell Harvesting

8 Organoids Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Organoids Market
  • 8.2 Impact Of The War In Ukraine On The Organoids Market
  • 8.3 Impact Of High Inflation On The Organoids Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Organoids Market Segmentation

  • 10.1 Global Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Organoids Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Organoids Market, Regional and Country Analysis

  • 11.1 Global Organoids Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Organoids Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Organoids Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Organoids Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Organoids Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Organoids Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Organoids Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Thermo Fisher Scientific Inc
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 Carl Zeiss AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial performance
  • 19.4 Corning Incorporated
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Performance
  • 19.5 Lonza Group Ltd
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 STEMCELL Technologies Inc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
  • 22.2 Bruker Corporation Acquired Acquifer Imaging
  • 22.3 Molecular Devices Acquired Cellesce
  • 22.4 Crown Bioscience International Acquired OcellO

23 Opportunities And Strategies

  • 23.1 Global Organoids Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Organoids Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Organoids Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Organoids Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer